Analyst Ratings for Benitec BioPharma (BNTC)
BNTC Rating Summary
BNTC Price Target Summary
- Highest: $35.00 (Oppenheimer)
- Lowest: $13.00 (Leerink Partners)
- Average: $22.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$22.60 (+101.2%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 77%
Avg. $ Target:
$22.60 (+101.2%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2024 | Oppenheimer | Andreas Argyrides | New Coverage | Outperform (N/A) |
35.00 (N/A) |
10.16 (11.23) |
10.53% | Details |
| 9/12/2024 | Guggenheim | Debjit Chattopadhyay | New Coverage | Buy (N/A) |
17.00 (N/A) |
8.44 (11.23) |
33.06% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
